ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer

Cato et al. utilize cistrome and transcriptome analyses in castration-resistant prostate cancer (CRPC) to reveal that the androgen receptor (AR) splice variant ARv7 functions as a transcriptional repressor and heterodimerizes with full-length AR at a subset of growth-suppressive genes to support CRPC growth.

from Cancer Cell http://bit.ly/2EbdhBa
إرسال تعليق (0)
أحدث أقدم